A Major Constituent of Green Tea, EGCG, Inhibits the Growth of a Human Cervical Cancer Cell Line, CaSki Cells, through Apoptosis, G1 Arrest, and Regulation of Gene Expression-Reference-Cited by-同舟云学术

A Major Constituent of Green Tea, EGCG, Inhibits the Growth of a Human Cervical Cancer Cell Line, CaSki Cells, through Apoptosis, G1 Arrest, and Regulation of Gene Expression

Published:2003-03 Issue:3 Volume:22 Page:217-224
ISSN:1044-5498
Container-title:DNA and Cell Biology
language:en
Short-container-title:DNA and Cell Biology

Author:

Ahn Woong Shick¹,Huh Seung Won,Bae Su-Mi,Lee Insu P.,Lee Jun Mo,Namkoong Sung Eun,Kim Chong Kook,Sin Jeong-Im

Affiliation:

1. Department of Obstetrics and Gynecology, College of Medicine, The Catholic University of Korea, Seoul, Korea

Publisher

Mary Ann Liebert Inc

Subject

Cell Biology,Genetics,Molecular Biology,General Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/104454903321655846

Reference35 articles.

1. Role of the Retinoblastoma (pRb)–E2F/DP Pathway in Cancer Chemopreventive Effects of Green Tea Polyphenol Epigallocatechin-3-gallate

2. Cell Cycle Dysregulation by Green Tea Polyphenol Epigallocatechin-3-Gallate

3. Green Tea Constituent Epigallocatechin-3-Gallate and Induction of Apoptosis and Cell Cycle Arrest in Human Carcinoma Cells

4. Effect of (-)-epigallocatechin gallate on leukemic blast cells from patients with acute myeloblastic leukemia

5. Green Tea Constituent (−)-Epigallocatechin-3-gallate Inhibits Topoisomerase I Activity in Human Colon Carcinoma Cells

Cited by 121 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Herbal Therapies for Cancer Treatment: A Review of Phytotherapeutic Efficacy;Biologics: Targets and Therapy;2024-09

2. Study of the antitumor activity of the combination baicalin and epigallocatechin gallate in a murine model of vincristine-resistant breast cancer;Pharmacia;2024-03-12

3. In Silico Investigations on the Synergistic Binding Mechanism of Functional Compounds with Beta-Lactoglobulin;Molecules;2024-02-22

4. Epigallocatechin Gallate for the Treatment of Benign and Malignant Gynecological Diseases—Focus on Epigenetic Mechanisms;Nutrients;2024-02-17

5. Epigallocatechin-3-gallate and its nanoformulation in cervical cancer therapy: the role of genes, MicroRNA and DNA methylation patterns;Cancer Cell International;2023-12-21